Open AccessOn-demand strategy as an alternative to conventionally scheduled post-transplant immunoadsorptions after ABO-incompatible kidney transplantation
Author(s) -
Jochen Wilpert,
Marcel Geyer,
Przemyslaw Pisarski,
Oliver Drognitz,
Christian Schulz-Huotari,
Anette Gropp,
Heike Goebel,
Peter Gerke,
Sven Teschner,
Gerd Walz,
Johannes Donauer
Publication year - 2007
Publication title -
nephrology, dialysis, transplantation/nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfm460
Subject(s) - medicine , abo blood group system , rituximab , immunoadsorption , titer , transplantation , surgery , kidney transplantation , dialysis , urology , immunology , antibody
Since 2001, approximately 100 ABO-incompatible kidney transplantations have been performed in Europe. The standard protocol, employed by most transplant centres, uses rituximab and scheduled pre-emptive antigen-specific immunoadsorption on post-operative days 3, 6 and 9.